Patent Assignment
Reel/Frame 066098/0927
Assignment of Assignor's Interest
Recorded: 2024-01-11
Pages: 3
Assignee
PRINCIPIA BIOPHARMA INC.
400 EAST JAMIE COURT, SUITE 302, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Modified Release Formulations of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl) Pyrazolo[3,4-D] Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl -4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 11, 2024
From: LIN, WU
To: QUOTIENT CLINICAL LIMITED
Reel/Frame 066098/0870 →
Assignment of Assignor's Interest
Jan 11, 2024
From: QUOTIENT CLINICAL LIMITED
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 066098/0981 →
Assignee Change of Address
Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →